Results 21 to 30 of about 21,516,320 (280)

Economic burden of lung cancer in Turkey: a cost of illness study from payer perspective

Health Economics Review, 2021
Background This study was designed to estimate economic burden of lung cancer in Turkey from payer perspective based on expert panel opinion on practice patterns in clinical practice.
Irfan Cicin, Ergun Oksuz, Nuri Karadurmus, Simten Malhan, Mahmut Gumus, Ulku Yilmaz, Levent Cansever, Halit Cinarka, Erdogan Cetinkaya, Murat Kiyik, Ahmet Ozet, Lung Cancer Report Study Group Turkey, on behalf of the Turkish Society of Lung Cancer, Lung Health and Intensive Care Association, University of Health Sciences, Turkish Society of Medical Oncology, National Cancer Institute, Turkish Respiratory Society   +17 more
doaj   +1 more source

Lyme borreliosis in Belgium: a cost-of-illness analysis

BMC Public Health, 2022
Background Lyme borreliosis (LB) is the most common tick-borne disease in Europe and North America, yet its economic burden remains largely unknown. This study aimed to estimate the economic cost associated with the different clinical manifestations of ...
Laurence Geebelen, Brecht Devleesschauwer, Tinne Lernout, Katrien Tersago, Yves Parmentier, Herman Van Oyen, Niko Speybroeck, Philippe Beutels   +7 more
doaj   +1 more source

Direct medical and non-medical costs of a one-year care pathway for early operable breast cancer: Results of a French multicenter prospective study

PLOS ONE, 2019
The organization of health care for breast cancer (BC) constitutes a public health challenge to ensure quality of care, while also controlling expenditure. Few studies have assessed the global care pathway of early BC patients, including a description of direct medical costs and their determinants. The aims of this multicenter prospective study were to
Delphine Héquet, Cyrille Huchon, Anne-Laure Soilly, Bernard Asselain, Helene Berseneff, Caroline Trichot, Aline Combes, Karine Alves, Thuy Nguyen, Roman Rouzier, Sandrine Baffert   +10 more
openaire   +4 more sources

Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study

JHEP Reports, 2020
Background & Aims: Non-alcoholic steatohepatitis (NASH) leads to cirrhosis and is associated with a substantial socioeconomic burden, which, coupled with rising prevalence, is a growing public health challenge.
Jamie O'Hara, Alan Finnegan, Harpal Dhillon, Leonardo Ruiz-Casas, Gabriel Pedra, Bethany Franks, George Morgan, Vanessa Hebditch, Bengt Jönsson, Mzwandile Mabhala, Tatjana Reic, Ingo Van Thiel, Vlad Ratziu, Manuel Romero-Gomez, Elisabetta Bugianesi, Jörn M. Schattenberg, Quentin M. Anstee   +16 more
doaj   +1 more source

Out-of-pocket expenditure on non-communicable diseases during Covid-19. A cross-sectional study from a semi-urban area of Kannur, Kerala

Clinical Epidemiology and Global Health, 2023
Introduction: Non-communicable disease (NCD) care was drastically affected during the COVID-19 pandemic. Therefore, this study aimed to estimate the cost incurred for NCD care during the pandemic and also to compare the cost of care of private and public
Resmi Mathew, Jeby Jose Olickal
doaj   +1 more source

Cost Analysis of Diagnosis and Treatment of Venous Thromboembolism in Total Knee Replacement Patients

Health Technology Assessment in Action
Background: Venous thromboembolism (VTE) is a condition that occurs when a blood clot forms in a vein. It includes deep vein thrombosis (DVT) and pulmonary embolism (PE).
Hadi Alizadeh siuki, Nikta Shobeiri, Amin Adel, Asma Rashki kemmak   +3 more
doaj   +1 more source

Fitted direct medical cost model (n = 87).

, 2019
Fitted direct medical cost model (n = 87).
Arthorn Riewpaiboon (3439406), A. Thi Win Shwe (6490502), Sitaporn Youngkong (6021329), Usa Chaikledkaew (4909543)   +3 more
core   +1 more source

Direct medical and non-medical costs for patients who accessed care in Laos.

, 2023
Direct medical and non-medical costs for patients who accessed care in Laos.
An Le Thanh Nguyen (16324592), Dung Chi Tham (16324613), Thai Quang Pham (10721718), Dang Hai Le (12368708), Audrey Dubot-Pérès (443414), Anthony A. Marfin (8967857), G. William Letson (16324607), Huong Minh Vu (16324610), Rose Slavkovsky (16324595), Hai Thanh Phan (12511630), Huong Thi Thu Nguyen (16324598), Manivanh Vongsouvath (188767), Elizabeth A. Ashley (8537562), Souphaphone Vannachone (16324601), Mayfong Mayxay (132900), Clint Pecenka (835779), Son Thai Dinh (16324604)   +16 more
core   +1 more source

Estimating the Direct Cost of Cancer in Nepal: A Cross-Sectional Study in a Tertiary Cancer Hospital

Frontiers in Public Health, 2019
Background: The increasing prevalence of cancer and lack of strong health financing system in low income countries like Nepal is exerting an enormous financial burden on cancer patients.
Shiva Ram Khatiwoda, Raja Ram Dhungana, Vishnu Prasad Sapkota, Sarswoti Singh   +3 more
doaj   +1 more source

Societal costs and health related quality of life in adult atopic dermatitis

BMC Health Services Research, 2023
Background Cost-of-illness studies are widely used for healthcare decision-making in chronic conditions. Our aim was to assess the cost-of-illness of adult atopic dermatitis (AD) from the societal perspective in Hungary.
Zsuzsanna Beretzky, Kamilla Koszorú, Fanni Rencz, Krisztina Hajdu, Júlia Borza, Katalin Bodai, Xu Feifei, Andrea Szegedi, Miklós Sárdy, Valentin Brodszky   +9 more
doaj   +1 more source